Nebius Just Raised $5 Billion in Convertible Notes Against a $1.4 Billion Revenue Base. Are We In a Bubble?
Aug 22, 2026 by Daniel SparksAnthropic's Investors Want a $2 Trillion IPO. The Last Record-Setting IPO Has Made Its Buyers Nothing in Two Months.The AI company's backers are talking up the biggest listing ever. The current record holder shows how the first two months can go.
Aug 22, 2026 by Adam SpataccoIs It Too Late to Buy Sandisk After Its 568% Run?Sandisk is the top-performing stock in the Nasdaq-100 this year.
Aug 22, 2026 by Patrick SandersHas Wall Street Entered the "Show Me" Phase of AI?Expectations for AI stocks appear to be changing.
Aug 22, 2026 by Emma NewberySenators Plan a Clarity Act Vote on Sept. 15. What Happens Next for Crypto?Crypto legislation could underpin huge growth for the industry, but there are still big hurdles ahead.
Aug 22, 2026 by Daniel SparksNebius Just Raised $5 Billion in Convertible Notes Against a $1.4 Billion Revenue Base. Are We In a Bubble?The AI cloud company borrowed three and a half times its annual revenue in one deal. The terms show what building at its pace costs.
Aug 22, 2026 by Motley Fool StaffAuthors in August: Vasant Dhar & “Thinking with Machines”For more than four decades, AI pioneer Vasant Dhar has had a front-row seat to artificial intelligence—teaching AI, building companies around it, and bringing machine learning to Wall Street.
Aug 22, 2026 by Robert IzquierdoRed Cat CEO Jeffrey Thompson Sells 150,000 Shares for $1.6 Million as the Stock Soars 24%The provider of advanced drone solutions for defense and national security reported a notable insider stock sale amid strong market gains.
Aug 22, 2026 by Motley Fool StaffCisco & Cerebras Orders Up, Stocks DownThough Cisco Systems and Cerebras have bulging order books, they face some major challenges.
Aug 22, 2026 by Steven Porrello$5,000 in Bloom Energy at Its COVID-Era Low Would Be Worth This Much NowIf you bought Bloom shares at one of its lowest prices ever, you would be sitting on a 6,633% gain today.
Aug 22, 2026 by Daniel SparksAnthropic's Investors Want a $2 Trillion IPO. The Last Record-Setting IPO Has Made Its Buyers Nothing in Two Months.The AI company's backers are talking up the biggest listing ever. The current record holder shows how the first two months can go.
Aug 22, 2026 by Adam SpataccoIs It Too Late to Buy Sandisk After Its 568% Run?Sandisk is the top-performing stock in the Nasdaq-100 this year.
Aug 22, 2026 by Patrick SandersHas Wall Street Entered the "Show Me" Phase of AI?Expectations for AI stocks appear to be changing.
Aug 22, 2026 by Courtney CarlsenGE Vernova's Backlog Is Bigger Than Some Countries' GDP. Here's What's Actually Inside the $176 Billion.GE Vernova is experiencing incredible growth, driven by soaring energy demands and the rapid expansion of data centers.
Aug 22, 2026 by Daniel SparksThe 30-Year Treasury Now Out-Yields Dividend Stocks by 2.2 Points. History Says What Followed the Last Time.The long bond hasn't yielded this much in 19 years. What happened to dividend payers the last time it did is worth remembering.
Aug 22, 2026 by Lyle DalyApple Announced Its Largest-Ever Stock Buyback Under Tim Cook's Leadership. Here's Why the Size of the Repurchase Program Matters for Shareholders.No company has bought back more of its shares than Apple over the last decade.
Aug 22, 2026 by Alex CarchidiUp 20% in 1 Day, is Hyperliquid Worth Buying Hand Over Fist Right Now?The decentralized crypto exchange appears to have an ally in the White House.
Aug 22, 2026 by Alex CarchidiInstitutional Investors Are Buying Hyperliquid Strategies. Should You?There's a lot more to their purchasing than a desire to own Hyperliquid itself.
Aug 22, 2026 by Jack DelaneyInsider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700Blum exercised stock options at $10.60 and sold at $76.76, capturing significant appreciation.
Aug 22, 2026 by Matthew BenjaminWhat Would Alan Greenspan Say About This Stock Market?Several valuation metrics suggest the current market is strongly overvalued.
Aug 22, 2026 by Reuben Gregg BrewerThis Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.Perrigo makes private-label over-the-counter drugs, which sounds like a reliable business, but there are warning signs to consider before you buy it.
Aug 22, 2026 by Maurie Backman3 of the Worst RMD Mistakes Retirees Make -- and How to Avoid ThemSteer clear of these to avoid financial pain.
Aug 22, 2026 by Robert IzquierdoReddit vs. Rigetti Computing: Which High-Growth Stock Is a Better Buy in 2026, the Social Media Giant or Rising Quantum Computing Company?Reddit just turned profitable with a 24.1% net margin, while Rigetti burns cash chasing quantum breakthroughs, a stark contrast in risk and reward.
Aug 22, 2026 by Brendan CoffeyStrive Director Pierre Rochard Buys 15,900 Shares After 86% Decline. Is a Rebound Coming?Rochard's $199,386 purchase establishes his first direct equity stake in the Bitcoin-focused asset manager, signaling confidence amid a challenging year for the stock.
